Filippinene - engelsk - FDA (Food And Drug Administration)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), panleucopenia virus (pli iv) and inactivated calicivirus (fcv 431) and (fcv g1 strains) - suspension for injection (sc) - 1 dose of 1 ml or 0.5 ml contains attenuated feline rhinotracheitis herpesvirus(fhv f2 strain)≥104.9 ccid50; inactivated feline calicivirus (fcv 431 and fcv g1 strains) antigens≥ 2.0 elisa u.; attenuated feline panleucopenia virus (pli iv) ≥103.5 ccid50

Den europeiske union - engelsk - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologicals for felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease.onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component.the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Den europeiske union - engelsk - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunologicals for felidae, - cats - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs.onsets of immunity have been demonstrated one week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components.the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Den europeiske union - engelsk - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - immunologicals for felidae, - cats - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs.onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

boehringer ingelheim vetmedica gmbh, ingelheim am rhein, germany (0000003115) -,55216,ingelheim/rhein,de - attenuated feline panleucopenia virus (pli iv); attenuated chlamydophila felis (905 strain); inactivated feline calicivirus (fcv 431 and g1 strains) antigens; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) - ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - attenuated feline panleucopenia virus (pli iv) 0,00 ly.insp.sv 0; attenuated chlamydophila felis (905 strain) 0,00 ly.insp.sv 0; inactivated feline calicivirus (fcv 431 and g1 strains) antigens 2,00 ly.insp.sv 0; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) 0,00 ly.insp.sv 0 - live feline rhinotracheitis virus + inactivated feline calicivirus antigen + live feline panleucopenia virus / parvovirus + live chlamydia - Γάτες - Χρόνοι αναμονής: Γάτες

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

boehringer ingelheim vetmedica gmbh, ingelheim am rhein, germany (0000003115) -,55216,ingelheim/rhein,de - attenuated feline panleucopenia virus (pli iv); inactivated feline calicivirus (fcv 431 and g1 strains) antigens; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) - ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - attenuated feline panleucopenia virus (pli iv) 0,00 ly.insp.sv 0; inactivated feline calicivirus (fcv 431 and g1 strains) antigens 2,00 ly.insp.sv 0; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) 0,00 ly.insp.sv 0 - live feline rhinotracheitis virus + live feline panleucopenia virus / parvovirus + inactivated feline calicivirus antigen - Γάτες - Χρόνοι αναμονής: Γάτες

Den europeiske union - nederlandsk - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunologicals voor felidae, - cats - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. onsets van immuniteit zijn aangetoond een week na de primaire vaccinatiekuur voor rhinotracheitis, calicivirus, chlamydophila felis en panleucopenie componenten. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Den europeiske union - engelsk - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals for felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease.onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component.the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

boehringer ingelheim vetmedica gmbh, ingelheim am rhein, germany (0000003115) -,55216,ingelheim/rhein,de - felv recombinant canarypox virus (vcp97); attenuated feline panleucopenia virus (pli iv); attenuated chlamydophila felis (905 strain); inactivated feline calicivirus (fcv 431 and g1 strains) antigens; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) - ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - felv recombinant canarypox virus (vcp97) 0,00 ly.insp.sv 0; attenuated feline panleucopenia virus (pli iv) 0,00 ly.insp.sv 0; attenuated chlamydophila felis (905 strain) 0,00 ly.insp.sv 0; inactivated feline calicivirus (fcv 431 and g1 strains) antigens 0,00 ly.insp.sv 0; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) 0,00 ly.insp.sv 0 - live feline rhinotracheitis virus + inactivated feline calicivirus antigen + live feline panleucopenia virus / parvovirus + live chlamydia + feline leukaemia recombinant live canarypox virus - Γάτες - Χρόνοι αναμονής: Γάτες

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

ΚΑΝΔΗΛΙΔΗ Α.Ε. Δ.Τ. candilidis sa (0000014548) Λεωφ. Κύμης & Ηλέκτρας 4β,15122,Μαρούσι, Αττική,gr - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain); attenuated feline panleucopenia virus (pli iv); inactivated feline calicivirus, strain 255 - ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ - - - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) 0,00 em.inj -; attenuated feline panleucopenia virus (pli iv) 0,00 em.inj -; inactivated feline calicivirus, strain 255 0,00 em.inj - - feline rhinotracheitis virus + feline calicivirus + feline panleucopenia virus / parvovirus - Γάτες - Χρόνοι αναμονής: Γάτες